Sign In
Buy BMY
$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
US FDA staff flag safety concerns from J&J, Bristol's CAR-T therapies
08:54am, Wednesday, 13'th Mar 2024
The U.S. Food and Drug Administration's staff reviewers on Wednesday raised safety concerns over the use of Johnson & Johnson's and Bristol-Myers Squibb's cancer therapies as earlier treatments for bl
Bristol Myers Squibb to Report Results for First Quarter 2024 on April 25, 2024
04:16pm, Monday, 11'th Mar 2024
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb to Report Results for First Quarter 2024 on April 25, 2024.
5 Top Dividend Stocks Passive Income Investors Should Buy in March
02:15pm, Sunday, 10'th Mar 2024
Sponsored: Tips for Investing A financial advisor can help you understand the advantages and disadvantages of investment properties.
Bristol-Myers Squibb: Finally Trending Up
05:51am, Friday, 08'th Mar 2024
Bristol-Myers Squibb has returned to sales growth after a period of declining sales, signaling a turnaround ahead. The biopharma continues to be hit by key drugs facing LOEs, but new drugs and acquisi
Bristol Myers Squibb (BMY) Stock Dips While Market Gains: Key Facts
06:51pm, Thursday, 07'th Mar 2024
In the most recent trading session, Bristol Myers Squibb (BMY) closed at $53.28, indicating a -0.19% shift from the previous trading day.
Bristol-Myers Squibb: Compelling Value From The New Products Portfolio And 4.5% Yield
08:52am, Thursday, 07'th Mar 2024
Bristol-Myers Squibb's stock has gained momentum after a difficult 2023, suggesting a positive outlook for the company.
Bristol Myers Squibb to Participate in Upcoming Investor Conferences
04:17pm, Wednesday, 06'th Mar 2024
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb to Participate in Upcoming Investor Conferences.
Millionaire's Blueprint: 7 Must-Have Stocks for Your Road to Wealthy Town
08:40am, Wednesday, 06'th Mar 2024
If you're searching for must-have stocks for wealth, look no further. In investing, identifying the right stocks leads to a fear of missing out.
Dividend Stocks That Could Deliver Life-Changing Returns
09:50am, Saturday, 02'nd Mar 2024
2022 was a dreadful year for investors, with the S&P 500 down almost 20% and the Nasdaq lower by a stunning 33%.
How To Invest In A SWAN Portfolio: The Near Perfect Portfolio Strategy
09:00am, Saturday, 02'nd Mar 2024
The Near Perfect Portfolio Strategy provides SWAN-like attributes and aims to meet income and growth goals while minimizing volatility and drawdowns. The strategy consists of three buckets: Dividend G
Bristol Myers Squibb (BMY) Rises But Trails Market: What Investors Should Know
06:51pm, Friday, 01'st Mar 2024
In the most recent trading session, Bristol Myers Squibb (BMY) closed at $50.89, indicating a +0.28% shift from the previous trading day.
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It
10:06am, Thursday, 29'th Feb 2024
Recently, Zacks.com users have been paying close attention to Bristol Myers (BMY). This makes it worthwhile to examine what the stock has in store.
Bristol Myers CEO says India to have largest R&D presence outside US by 2025
03:29am, Tuesday, 27'th Feb 2024
Bristol Myers Squibb aims to expand its research and development presence in India and expects its newly inaugurated Hyderabad facility to become its largest unit outside the U.S. by 2025, CEO Christo
New Strong Sell Stocks for February 26th
06:46am, Monday, 26'th Feb 2024
BXMT, BMY and CWEN have been added to the Zacks Rank #5 (Strong Sell) List on February 26, 2023.
Bristol Myers' (BMY) Krazati sNDA for CRC Gets Priority Review
10:11am, Wednesday, 21'st Feb 2024
Bristol Myers (BMY) announces FDA's acceptance of the sNDA seeking approval for the Krazati/Erbitux combo therapy to treat CRC patients. A final decision is expected on Jun 21, 2024.
